Dr Panagiotis Koliou

Dr Panagiotis Koliou is a Consultant Medical Oncologist at Royal Surrey NHS Foundation Trust, specialising in the treatment of breast cancer and melanoma. He graduated in Medicine from the University of Ioannina in Greece and also holds an honours degree in Biochemistry from Benedictine University in the USA. He went on to complete a master’s degree in Clinical Biochemistry and Molecular Biology at the University of Surrey, followed by a PhD in Medical Oncology, awarded with First Class honours in 2016.

His oncology training took place at both Aristotle University of Thessaloniki and University College London Hospital. Dr Koliou is actively involved in research and leads several breast cancer clinical trials as principal investigator. His interests include prognostic and predictive biomarkers, angiogenesis, and combining immunotherapy with novel compounds and drug therapies.

He has presented his findings at international conferences and published widely in peer-reviewed medical journals. Currently based at St Luke’s Cancer Centre in Guildford, Dr Koliou is researching the use of immunotherapy for breast cancer and melanoma through the virtual Surrey Cancer Research Institute, exploring more targeted and less aggressive treatment options for patients.

In addition to his clinical and academic work, he serves as a trustee for Topic of Cancer, a charity that supports cancer immunotherapy research at the University of Surrey.